Dysuria - CISMeF

Preferred Label : Dysuria;

NCIt definition : Pain or discomfort during urination.;

Alternative definition : FDA: Difficult or painful urination.;

FDA table : Patient Code (Appendix B);

Codes from synonyms : 2684;

Details

Origin ID

C2999;

UMLS CUI

C0013428;

Currated CISMeF NLP mapping
- DYSURIA [WHO-ART Preferred Term]
- Dysuria [PASCAL descriptor]
- Dysuria [ICD-9 code]
- Dysuria [ICD-10 Sub-category]
- Dysuria [ICD-11 Subcategory]
- Dysuria [ICD-10 Sub-category (who)]
- Dysuria [HPO term]
- Dysuria [MedDRA Preferred Term]
- Dysuria (finding) [SNOMED CT concept]
- dysuria [Disease (Nov.)]
- dysuria [MeSH Descriptor]
- dysuria [MeSH concept]
- dysuria, nos [SNOMED Notion]
- dysuria/painful urination [ICPC-2 Rubric]
Peut être observé dans la(les) pathologie(s)
- Advanced Vaginal Adenocarcinoma [NCIt concept]
- Advanced Vaginal Adenosquamous Carcinoma [NCIt concept]
- Bladder Adenocarcinoma [NCIt concept]
- Bladder Adenocarcinoma, Not Otherwise Specified [NCIt concept]
- Bladder Clear Cell Adenocarcinoma [NCIt concept]
- Bladder Diffuse Clear Cell Adenocarcinoma [NCIt concept]
- Bladder Endometrioid Adenocarcinoma [NCIt concept]
- Bladder Enteric Type Adenocarcinoma [NCIt concept]
- Bladder Hepatoid Adenocarcinoma [NCIt concept]
- Bladder Mixed Adenocarcinoma [NCIt concept]
- Bladder Mucinous Adenocarcinoma [NCIt concept]
- Bladder Papillary Clear Cell Adenocarcinoma [NCIt concept]
- Bladder Signet Ring Cell Adenocarcinoma [NCIt concept]
- Bladder Squamous Cell Carcinoma [NCIt concept]
- Bladder Tubulo-Cystic Clear Cell Adenocarcinoma [NCIt concept]
- Bladder Verrucous Carcinoma [NCIt concept]
- Human Papillomavirus-Related Vaginal Adenocarcinoma [NCIt concept]
- Infiltrating Bladder Urothelial Carcinoma, Lymphoma-Like Variant [NCIt concept]
- Invasive Bladder Clear Cell (Glycogen-Rich) Urothelial Carcinoma [NCIt concept]
- Invasive Bladder Conventional Urothelial Carcinoma [NCIt concept]
- Invasive Bladder Giant Cell Urothelial Carcinoma [NCIt concept]
- Invasive Bladder Large Nested Urothelial Carcinoma [NCIt concept]
- Invasive Bladder Lipid-Rich Urothelial Carcinoma [NCIt concept]
- Invasive Bladder Lymphoepithelioma-Like Carcinoma [NCIt concept]
- Invasive Bladder Microcystic Urothelial Carcinoma [NCIt concept]
- Invasive Bladder Micropapillary Urothelial Carcinoma [NCIt concept]
- Invasive Bladder Nested Urothelial Carcinoma [NCIt concept]
- Invasive Bladder Plasmacytoid Urothelial Carcinoma [NCIt concept]
- Invasive Bladder Poorly Differentiated Urothelial Carcinoma [NCIt concept]
- Invasive Bladder Sarcomatoid Urothelial Carcinoma [NCIt concept]
- Invasive Bladder Sarcomatoid Urothelial Carcinoma with Heterologous Elements [NCIt concept]
- Invasive Bladder Sarcomatoid Urothelial Carcinoma without Heterologous Elements [NCIt concept]
- Invasive Bladder Tubular Urothelial Carcinoma [NCIt concept]
- Invasive Bladder Urothelial Carcinoma [NCIt concept]
- Invasive Bladder Urothelial Carcinoma with Glandular Differentiation [NCIt concept]
- Invasive Bladder Urothelial Carcinoma with Squamous Differentiation [NCIt concept]
- Invasive Bladder Urothelial Carcinoma with Trophoblastic Differentiation [NCIt concept]
- Localized Muscle Invasive Bladder Urothelial Carcinoma [NCIt concept]
- Localized Non-Muscle Invasive Bladder Urothelial Carcinoma [NCIt concept]
- Locally Advanced Bladder Adenocarcinoma [NCIt concept]
- Metastatic Bladder Adenocarcinoma [NCIt concept]
- Metastatic Bladder Clear Cell (Glycogen-Rich) Urothelial Carcinoma [NCIt concept]
- Metastatic Bladder Giant Cell Urothelial Carcinoma [NCIt concept]
- Metastatic Bladder Lipid-Rich Urothelial Carcinoma [NCIt concept]
- Metastatic Bladder Micropapillary Urothelial Carcinoma [NCIt concept]
- Metastatic Bladder Nested Urothelial Carcinoma [NCIt concept]
- Metastatic Bladder Plasmacytoid Urothelial Carcinoma [NCIt concept]
- Metastatic Bladder Sarcomatoid Urothelial Carcinoma [NCIt concept]
- Metastatic Vaginal Adenocarcinoma [NCIt concept]
- Metastatic Vaginal Adenosquamous Carcinoma [NCIt concept]
- Muscle Invasive Bladder Urothelial Carcinoma [NCIt concept]
- Non-Muscle Invasive Bladder Urothelial Carcinoma [NCIt concept]
- Recurrent Bladder Adenocarcinoma [NCIt concept]
- Recurrent Bladder Squamous Cell Carcinoma [NCIt concept]
- Recurrent Muscle Invasive Bladder Urothelial Carcinoma [NCIt concept]
- Recurrent Non-Muscle Invasive Bladder Urothelial Carcinoma [NCIt concept]
- Refractory Non-Muscle Invasive Bladder Urothelial Carcinoma [NCIt concept]
- Schistosoma Hematobium-Related Bladder Squamous Cell Carcinoma [NCIt concept]
- Schistosoma Hematobium-Related Bladder Verrucous Carcinoma [NCIt concept]
- Stage 0 Bladder Adenocarcinoma AJCC v6 and v7 [NCIt concept]
- Stage 0 Bladder Squamous Cell Carcinoma AJCC v6 and v7 [NCIt concept]
- Stage I Bladder Adenocarcinoma AJCC v6 and v7 [NCIt concept]
- Stage I Bladder Urothelial Carcinoma AJCC v6 and v7 [NCIt concept]
- Stage I Squamous Cell Carcinoma of the Bladder AJCC v6 and v7 [NCIt concept]
- Stage II Bladder Adenocarcinoma AJCC v6 and v7 [NCIt concept]
- Stage II Bladder Squamous Cell Carcinoma AJCC v6 and v7 [NCIt concept]
- Stage II Bladder Urothelial Carcinoma AJCC v6 and v7 [NCIt concept]
- Stage III Bladder Adenocarcinoma AJCC v6 and v7 [NCIt concept]
- Stage III Bladder Squamous Cell Carcinoma AJCC v6 and v7 [NCIt concept]
- Stage III Bladder Urothelial Carcinoma AJCC v6 and v7 [NCIt concept]
- Stage IV Bladder Adenocarcinoma AJCC v7 [NCIt concept]
- Stage IV Bladder Squamous Cell Carcinoma AJCC v7 [NCIt concept]
- Stage IV Bladder Urothelial Carcinoma AJCC v7 [NCIt concept]
- Unresectable Bladder Adenocarcinoma [NCIt concept]
- Urachal Adenocarcinoma [NCIt concept]
- Urachal Squamous Cell Carcinoma [NCIt concept]
- Vaginal Adenocarcinoma [NCIt concept]
- Vaginal Adenocarcinoma of Skene Gland Origin [NCIt concept]
- Vaginal Adenoid Basal Carcinoma [NCIt concept]
- Vaginal Adenoid Cystic Carcinoma [NCIt concept]
- Vaginal Adenosquamous Carcinoma [NCIt concept]
- Vaginal Basaloid Squamous Cell Carcinoma [NCIt concept]
- Vaginal Clear Cell Adenocarcinoma [NCIt concept]
- Vaginal Endometrioid Adenocarcinoma [NCIt concept]
- Vaginal Keratinizing Squamous Cell Carcinoma [NCIt concept]
- Vaginal Mesonephric Adenocarcinoma [NCIt concept]
- Vaginal Mucinous Adenocarcinoma [NCIt concept]
- Vaginal Mucinous Adenocarcinoma, Gastric-Type [NCIt concept]
- Vaginal Mucinous Adenocarcinoma, Intestinal-Type [NCIt concept]
- Vaginal Non-Keratinizing Squamous Cell Carcinoma [NCIt concept]
- Vaginal Small Cell Neuroendocrine Carcinoma [NCIt concept]
- Vaginal Undifferentiated Carcinoma [NCIt concept]
- Vulvar Melanoma [NCIt concept]
Semantic type(s)
- Sign or Symptom [UMLS semantic type]
UMLS correspondences (same concept)
- DYSURIA [WHO-ART Preferred Term]
- Dysuria [ICD-9 code]
- Dysuria [ICD-10 Sub-category]
- Dysuria [HPO term]
- Dysuria [PASCAL descriptor]
- Dysuria [ICD-11 Subcategory]
- Dysuria [ICD-10 Sub-category (who)]
- Dysuria [MedDRA Preferred Term]
- Dysuria (finding) [SNOMED CT concept]
- MICTURITION PAINFUL [WHO-ART Included Term]
- Micturition painful [MedDRA LLT]
- Pain associated with micturition [ICD-10 category]
- Painful micturition, unspecified [ICD-10 Sub-category]
- Painful urination [MedDRA LLT]
- Urination pain [MedDRA LLT]
- dysuria [Disease (Nov.)]
- dysuria [MeSH concept]
- dysuria [MeSH Descriptor]
- dysuria, nos [SNOMED Notion]
- dysuria/painful urination [ICPC-2 Rubric]
concept_is_in_subset
- CDRH Health Effects - Clinical Signs and Symptoms or Conditions Terminology [NCIt concept]
- FDA Center For Devices and Radiological Health Terminology [NCIt concept]
- NICHD Terminology [NCIt concept]
- Pediatric Adverse Events Terminology [NCIt concept]
- Pediatric Adverse Events Terminology Mapped to MedDRA [NCIt concept]
- Pediatric Nephrology Terminology [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients